Filter Results:
(309)
Show Results For
- All HBS Web
(393)
- News (48)
- Research (309)
- Multimedia (1)
- Faculty Publications (246)
Show Results For
- All HBS Web
(393)
- News (48)
- Research (309)
- Multimedia (1)
- Faculty Publications (246)
Sort by
- January 2002 (Revised July 2002)
- Case
Vialog Corporation
By: Richard G. Hamermesh and Michele Lutz
Traces the origin of Vialog Corp.--from its founding in 1996 through a roll-up of several independent teleconferencing companies in 1997 and its initial public offering (1999) and eventually to a potential merger or acquisition in June 2000. The company has grown... View Details
Keywords: History; Business Exit or Shutdown; Internet and the Web; Corporate Entrepreneurship; Partners and Partnerships; Initial Public Offering; Business Growth and Maturation; Mergers and Acquisitions; Business Processes; Information Technology Industry; Europe
Hamermesh, Richard G., and Michele Lutz. "Vialog Corporation." Harvard Business School Case 802-008, January 2002. (Revised July 2002.)
- January 2001 (Revised April 2001)
- Teaching Note
Lawyers & Leases TN
By: Richard G. Hamermesh and Michele Lutz
Teaching Note for (9-801-166). View Details
- November 1980 (Revised March 1981)
- Case
International Harvester (C)
By: Richard G. Hamermesh and Evelyn T. Christiansen
Hamermesh, Richard G., and Evelyn T. Christiansen. "International Harvester (C)." Harvard Business School Case 381-057, November 1980. (Revised March 1981.)
- October 1980 (Revised June 1986)
- Case
International Harvester (B1)
By: Richard G. Hamermesh and Evelyn T. Christiansen
Hamermesh, Richard G., and Evelyn T. Christiansen. "International Harvester (B1)." Harvard Business School Case 381-053, October 1980. (Revised June 1986.)
- October 1979 (Revised March 1986)
- Case
PC&D, Inc.
By: Evelyn T. Christiansen and Richard G. Hamermesh
Covers history of PC&D from 1960 to 1975 as it grows from a single business firm to a diversified firm. Emphasizes the use of subsidiaries for product development and fast growth. Other issues include problems of a new CEO in keeping control of fast growing divisions. View Details
Keywords: Leadership; Business Subsidiaries; Diversification; Growth Management; Product Development
Christiansen, Evelyn T., and Richard G. Hamermesh. "PC&D, Inc." Harvard Business School Case 380-072, October 1979. (Revised March 1986.)
- February 1979 (Revised October 1980)
- Case
Mitek Corp.
By: Richard G. Hamermesh and Evelyn T. Christiansen
Hamermesh, Richard G., and Evelyn T. Christiansen. "Mitek Corp." Harvard Business School Case 379-110, February 1979. (Revised October 1980.)
- February 1975 (Revised October 1985)
- Teaching Note
Fuqua Industries (A), (B), and (C), Teaching Note
- December 1974 (Revised May 1983)
- Case
Fuqua Industries (A)
Salter, Malcolm S., and Richard G. Hamermesh. "Fuqua Industries (A)." Harvard Business School Case 375-189, December 1974. (Revised May 1983.)
- December 12, 2018
- Article
Impact Investing Could Accelerate the Fight Against Cancer
By: Richard G. Hamermesh and Kathryn E. Giusti
Hamermesh, Richard G., and Kathryn E. Giusti. "Impact Investing Could Accelerate the Fight Against Cancer." Harvard Business Review (website) (December 12, 2018).
- April 2018
- Teaching Note
Hawk Electronics, Inc. (Brief Case)
By: Richard G. Hamermesh and John J. Lafkas
Teaching Note for HBS Brief Case 918-521. View Details
- January–February 1984
- Article
Manage Beyond Portfolio Analysis
By: Richard G. Hamermesh and Roderick E. White
Hamermesh, Richard G., and Roderick E. White. "Manage Beyond Portfolio Analysis." Harvard Business Review 62, no. 1 (January–February 1984): 103–109.
- March 2015 (Revised September 2016)
- Case
Terrapin Laboratory
By: Richard G. Hamermesh and Joseph B. Fuller
Describes the formation and rapid growth of a drug testing company. The company needs to decide whether to enter the painkiller testing market, in addition to growing its drug treatment center business. The associated teaching materials provide students the opportunity... View Details
Keywords: Business Growth; Entrepreneurial Management; Entrepreneurship; Growth Strategy; Market Entry; Venture Capital; Growth Management; Expansion; Financing and Loans; Health Care and Treatment; Health Testing and Trials; Business Startups; Pharmaceutical Industry; Health Industry
Hamermesh, Richard G., and Joseph B. Fuller. "Terrapin Laboratory." Harvard Business School Case 315-098, March 2015. (Revised September 2016.)
- June 2004
- Teaching Note
Pre-Money / Post-Money Tutorial (Instructor Guide)
By: Richard G. Hamermesh and Michael J. Roberts
Teaching Note to (9-803-703). View Details
- May 2003
- Supplement
Jim Sharpe: Extrusion Technology, Inc.
By: Richard G. Hamermesh and Paul W. Marshall
Jim Sharpe discusses his early career at General Electric to his decision to purchase and run a small company. The discussion includes a detailed acquisition financing proposal, which resulted in Sharpe being able to raise virtually all of the financing from some... View Details
Keywords: Personal Development and Career; Entrepreneurship; Business Startups; Mergers and Acquisitions; Financing and Loans
Hamermesh, Richard G., and Paul W. Marshall. "Jim Sharpe: Extrusion Technology, Inc." Harvard Business School Video Supplement 803-803, May 2003.
- June 1995
- Teaching Note
Cleveland Twist Drill (A) and (B) TN
By: Richard G. Hamermesh and Joseph L. Bower
Teaching Note for (9-384-083) and (9-384-163). View Details
- August 2013 (Revised October 2013)
- Case
MedImmune Ventures
By: Richard G. Hamermesh and David Lane
Ron Laufer is the new Senior Managing Director of MedImmune Ventures, the corporate venture capital arm of AstraZeneca, a leading pharmaceuticals firm. Laufer has to decide whether to pursue a high-potential, but very risky, early-stage investment. The decision Laufer... View Details
Keywords: MedImmune; MedImmune Ventures; AstraZeneca; NeuProtect; Corporate Venturing; Biotechnology; Venture Investing; Venture Capital; Health Care and Treatment; Pharmaceutical Industry; Financial Services Industry; Biotechnology Industry; United States; Australia; Europe; London
Hamermesh, Richard G., and David Lane. "MedImmune Ventures." Harvard Business School Case 814-023, August 2013. (Revised October 2013.)
- May 2012
- Supplement
Westlake Lanes: How Can This Business Be Saved? Spreadsheet for Instructors (Brief Case)
By: Richard G. Hamermesh and Alisa Zalosh
- November 2012
- Supplement
Sugar Bowl, Spreadsheet for Students (Brief Case) (CW)
By: Richard G. Hamermesh and Alisa Zalosh
- December 2012
- Teaching Note
Gene Patents (A) (TN)
By: Richard G. Hamermesh and Matthew Preble
This is the teaching note for case Gene Patents (A). In March 2010, U.S. District Court Judge Robert Sweet overturned 30 years of legal precedent and ruled that unaltered human genes could not be patented. This case reviews patent law and how it relates to our... View Details